US2002094990A1PendingUtilityA1

Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives

Priority: Dec 2, 1986Filed: Nov 6, 2001Published: Jul 18, 2002
Est. expiryDec 2, 2006(expired)· nominal 20-yr term from priority
A61K 31/131C07C 211/14A61K 31/506A61K 31/505C07C 209/08A01N 33/04A61K 31/13C07C 209/62A61K 31/785A01N 43/54C07D 239/04A61K 31/135
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to anti-neoplastic and anti-psoriasis pharmaceutical compositions and methods of treatment and to insecticidal compositions and methods of controlling the growth of insects.

Claims

exact text as granted — not AI-modified
claims:  
     
         1 . A pharmaceutical composition comprising an anti-neoplastic effective amount of a compound having one of the formulae:  
       
         
           
           
               
               
           
         
       
       R 1 —H  1 H—(CH 2 ) 3 —N 2 H—(CH 2 ) 3 —N 3 H-—(CH 2 ) 4 —N 4 H—(CH 2 ) 3 —N 5 H—(CH 2 ) 3 —N 6 H—R 6   ( II );  
       
         
           
           
               
               
           
         
         Wherein: R 1  and R 6  may be the same or different and are 1I, alkyl or aralkyl having from 1 to 12 carbon atoms;  
         R 2 -R 5  may be the same or different and are H, R 1  or R 6 ;  
         R 7  is H, alkyl, aryl or aralkyl having from 1 to 12 carbon atoms;  
         m is an integer from 3 to 6, inclusive;  
         n is an integer from 3 to 6, inclusive; or  
         (IV), a salt thereof with a pharmaceutically acceptable acid; and a pharmaceutically acceptable carrier therefor.  
       
     
     
         2 . A composition according to  claim 1  wherein m is 3 and n is 4.  
     
     
         3 . A composition according to  claim 1  wherein m and n are 3.  
     
     
         4 . A composition according to  claim 1  wherein m and n are 4.  
     
     
         5 . A composition according to  claim 1  wherein R 1  and R 6  are alkyl.  
     
     
         6 . A composition according to  claim 1  wherein R 1  and R 6  are aralkyl.  
     
     
         7 . A composition according to  claim 1  wherein R 1  and R 6  are methyl.  
     
     
         8 . A composition according to  claim 1  wherein R 1  and R 6  are ethyl.  
     
     
         9 . A composition according to  claim 1  wherein R 1  and R 6  are propyl.  
     
     
         10 . A composition according to  claim 1  wherein R 1  and R 6  are benzyl.  
     
     
         11 . A method of treating a human or non-human animal in need of anti-neoplastic therapy comprising administering to said animal an anti-neoplastic effective amount of a compound having one of the formulae:  
       
         
           
           
               
               
           
         
       
       R 1 —N 1 H—(CH 2 ) 3 —N 2 H—(CH 2 ) 3 —N 3 H—(CH 2 ) 4 —N 4 H—(CH 2 ) 3 —N 5 H—(CH 2 ) 3 —N 6 H—R 6   ( III )  
       
         
           
           
               
               
           
         
         Wherein: R 1  and R 6  may be the same or different and are H, alkyl or aralkyl having from 1 to 12 carbon atoms, provided that R 1  and R6 are not H;  
         R 7  is H, alkyl, aryl or aralkyl having from 1 to 12 carbon atoms;  
         m is an integer from 3 to 6, inclusive;  
         n is an integer from 3 to 6, inclusive; or  
         (IV), a salt thereof with a pharmaceutically acceptable acid.  
       
     
     
         12 . A method according to  claim 11  wherein m is 3 and n is 4.  
     
     
         13 . A method according to  claim 11  wherein m and n are 3.  
     
     
         14 . A method according to  claim 11  wherein m and n are 4.  
     
     
         15 . A method according to  claim 11  wherein R 1  and R 6  are alkyl.  
     
     
         16 . A method according to  claim 11  wherein R 1  and R 6  are aralkyl.  
     
     
         17 . A method according to  claim 11  wherein R 1  and R 6  are methyl.  
     
     
         18 . A method according to  claim 11  wherein R 1  and R 6  are ethyl.  
     
     
         19 . A method according to  claim 11  wherein R 1  and R 6  are propyl.  
     
     
         20 . A method according to  claim 11  wherein R 1  and R 6  are benzyl.  
     
     
         21 . A compound having the formula:  
       
         
           
           
               
               
           
         
         Wherein: R 1 -R 6  may be the same or different and are methyl, propyl, butyl, pentyl, benzyl or β,β, β,-trifluoroethyl;  
         m is an integer from 3 to 6, inclusive;  
         n is an integer from 3 to 6, inclusive, or a salt thereof with an acid.  
       
     
     
         22 . A compound according to  claim 21  wherein R 1  and R 6  are propyl.  
     
     
         23 . A compound according to  claim 21  wherein R 1  and R 6  are benzyl.  
     
     
         24 . A compound according to  claim 21  wherein m is 3and n Is 4.  
     
     
         25 . A compound according to  claim 21  wherein m and n are 3.  
     
     
         26 . A compound according to  claim 21  wherein m and n are 4.  
     
     
         27 . A compound having the formula:  
       R 1 —N 1 H—(CH 2 ) 3 —N 2 H—(CH 2 ) 3 N 3 H—(CH 2 ) 4 —N 4 H—(CH 2 ) 3 —N 5 H—(CH 2 ) 3 N 6 H—R 6   ( II );  Wherein: R 1  and R 6  may be the same or different and are alkyl or aralkyl having from 1 to 12 carbon atoms, or a salt thereof with an acid.    
     
     
         28 . A compound according to  claim 27  wherein R 1  and R 6  are alkyl.  
     
     
         29 . A compound according to  claim 27  wherein R 1  and R 6  are aralkyl.  
     
     
         30 . A compound according to  claim 27  wherein R 1  and R 6  are methyl.  
     
     
         31 . A compound according to  claim 27  wherein R 1  and R 6  are ethyl.  
     
     
         32 . A compound according to  claim 27  wherein R 1  and R 6  are propyl.  
     
     
         33 . A compound according to  claim 27  wherein R 1  and, R 6  are benzyl.  
     
     
         34 . A compound having the formula:  
       
         
           
           
               
               
           
         
         Wherein: R 1  and R 6  may be the same or different and are alkyl or aralkyl having from 1 to 12 carbon atoms;  
         R 7  is H, alkyl aryl or aralkyl having from 1 to 12 carbon atoms;  
         n is an integer from 3 to 6, inclusive, or a salt thereof with an acid.  
       
     
     
         35 . A compound according to  claim 34  wherein R 1  and R 6  are alkyl.  
     
     
         36 . A compound according to  claim 34  wherein R 1  and R 6  are aralkyl.  
     
     
         37 . A compound according to  claim 34  wherein R 1  and R 6  are methyl.  
     
     
         38 . A compound according to  claim 34  wherein R 1  and R 6  are ethyl.  
     
     
         39 . A compound according to  claim 34  wherein R 1  and R 6  are propyl.  
     
     
         40 . A compound according to  claim 34  wherein R 1  and R 6  are benzyl.  
     
     
         41 . A compound according to  claim 34  wherein n is 3.  
     
     
         42 . A compound according to  claim 34  wherein n is 4.  
     
     
         43 . A pharmaceutical composition comprising an anti-viral, anti-psoriasis or anti-retroviral effective amount of a compound having one of the formula:  
       
         
           
           
               
               
           
         
       
       R 1 —N 1 H—(CH 2 ) 3 —N 2 H—(CH 2 ) 3 —N 3 H—(CH 2 ) 4 —N 4 —(CH 2 ) 3 —N 5 H—(CH 2 ) 3 —N 6 H—R 6   ( II )  
       
         
           
           
               
               
           
         
         Wherein: R 1  and R 6  may be the same or different and are H. alkyl or aralkyl having from 1 to 12 carbon atoms;  
         R 2 -R 5  may be the same or different and are H, R 1  or R 6 ;  
         R 7  is H, alkyl, aryl aralkyl having from 1 to 12 carbon atoms;  
         m is an integer from 3 to 6, inclusive;  
         n is an integer from 3 to 6, inclusive; or, (IV), a salt thereof  
         with a pharmaceutically acceptable acid; and a pharmaceutically acceptable carrier therefor.  
       
     
     
         44 . A method of treating a human or non-human animal in need of anti-viral, anti-psoriasis or anti-retroviral therapy comprising administering to said animal an anti-viral, anti-psoriasis or anti-retroviral effective amount of a compound having one of the formulae:  
       
         
           
           
               
               
           
         
       
       R 1 —N 1 H—(CH 2 ) 3 —N 2 H—(CH 2 ) 3 —N 3 H—(CH 2 ) 4 —N 4 H—(CH 2 ) 3 —N 5 H—(CH 2 ) 3 —N 6 H—R 6   ( II );  
       
         
           
           
               
               
           
         
         Wherein: R 1  and R 6  may be the same or different and are H, alkyl or aralkyl having from 1 to 12 carbon atoms, provided that R 1  and R 6  are not H;  
         R 7  is H, alkyl, aryl or aralkyl having from 1 to 12 carbon atoms; m is an integer from 3 to 6, inclusive; and  
         n is an integer from 3 to 6, inclusive; or (IV), a salt thereof  
         with a pharmaceutically acceptable acid.  
       
     
     
         45 . An insecticidal composition comprising, an insecticidably effective amount of a compound having one of the formula:  
       
         
           
           
               
               
           
         
       
       R 1 —N 1 H—(CH 2 —N 2 H—(CH 2 ) 3 —N 3 H—(CH 2 ) 4 —N 4 H—(CH 2 ) 3 —N 5 H—(CH 2 ) 3 —N 6 H—R 6   ( II )                    Wherein: R 1  and R 6  may be the same or different and are H. alkyl or aralkyl having from 1 to 12 carbon atoms;    R 2 -R 5  may be the same or different and are H, R 1  or R 6 ;    R 7  is H, alkyl, aryl, aralkyl having from 1 to 12 carbon atoms;    m is an integer from 3 to 6, inclusive;    n is an integer from 3 to 6 inclusive; or (IV), a salt thereof with an acid and a carrier therefor.    
     
     
         46 . A method of controlling the growth of insects comprising administering to said insects an insecticidal effective amount of a compound having one of the formulae:  
       
         
           
           
               
               
           
         
       
       R 1 —N 1 H—(CH 2 ) 3 —N 2 H—(CH 2 ) 3 —N 3 H—(CH 2 ) 4 —N 4 H—(CH 2 ) 3 —N 5 H—(CH 2 ) 3 —N 6 H—R 6   ( II );  
       
         
           
           
               
               
           
         
         Wherein: R 1  and R 6  may be the same or different and are H, alkyl or aralkyl having from 1 to 12 carbon atoms, provided that R 1  and R 6  are not H;  
         R 7  is H, alkyl, aryl or aralkyl having from 1 to 12 carbon atoms;  
         m is an integer from 3 to 6, inclusive; and  
         n is an integer from 3 to 6, inclusive; or (IV), a salt thereof  
         with an acid and a carrier therefor.

Join the waitlist — get patent alerts

Track US2002094990A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.